News from amyris, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jun 05, 2023, 08:37 ET AMYRIS INITIATES STRATEGIC TRANSFORMATION PROGRAM AND SECURES FUNDING

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its...

May 19, 2023, 08:00 ET AMYRIS COMPLETES LICENSE FOR SUPPLY OF SUSTAINABLE SQUALENE

EMERYVILLE, Calif., May 19, 2023 Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to...

May 09, 2023, 16:05 ET AMYRIS, INC. REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its...

May 02, 2023, 08:00 ET AMYRIS TO HOST FIRST QUARTER 2023 FINANCIAL RESULTS CONFERENCE CALL ON MAY 9

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its...

Apr 24, 2023, 08:59 ET AMYRIS REPORTS Q1 2023 REVENUE

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its...

Apr 05, 2023, 08:00 ET AMYRIS CLOSES STRATEGIC TRANSACTION WITH GIVAUDAN

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its...

Mar 15, 2023, 16:11 ET AMYRIS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS

Fourth quarter Consumer revenue of $52.8 million increased 64% over the prior year and was another record quarter. Core revenue of $75.8 million grew ...

Feb 28, 2023, 08:00 ET AMYRIS TO HOST FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS CONFERENCE CALL ON MARCH 15, 2023

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its...

Feb 22, 2023, 06:00 ET GIVAUDAN TO ACQUIRE PORTFOLIO OF MAJOR COSMETIC INGREDIENTS FROM AMYRIS AND TO ESTABLISH STRATEGIC PARTNERSHIP FOR NATURAL, SUSTAINABLY SOURCED INGREDIENTS FOR THE BEAUTY INDUSTRY

As part of its 2025 strategy to provide new and superior product offerings to expand its Active Beauty business, Givaudan, the global leader in...

Jan 30, 2023, 08:00 ET AMYRIS LAUNCHES 4U BY TIA™ HAIRCARE LINE EXCLUSIVELY AT WALMART

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its...

Jan 04, 2023, 08:00 ET AMYRIS TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTH CARE CONFERENCE

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its...

Dec 29, 2022, 08:00 ET AMYRIS ANNOUNCES $50 MILLION REGISTERED DIRECT OFFERING AND CONCURRENT PRIVATE PLACEMENT

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its...

Dec 27, 2022, 08:00 ET AMYRIS SUCCESSFULLY ADVANCES STRATEGIC TRANSACTION

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its...

Nov 30, 2022, 08:00 ET AMYRIS CONSUMER BRANDS DELIVER 80% CYBER MONDAY LIKE-FOR-LIKE GROWTH

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its...

Nov 28, 2022, 08:56 ET AMYRIS CONSUMER BRANDS DELIVER RECORD BLACK FRIDAY WEEK SALES

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its...

Nov 08, 2022, 16:05 ET AMYRIS, INC. REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its...

Nov 01, 2022, 08:00 ET AMYRIS TO HOST THIRD QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL ON NOVEMBER 8

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its...

Oct 25, 2022, 08:00 ET Amyris and World Wildlife Fund Announce Partnership to Protect Biodiversity

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its...

Oct 24, 2022, 08:00 ET AMYRIS SUCCESSFULLY LAUNCHES TWO NEW CONSUMER BRANDS

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its...

Oct 11, 2022, 08:43 ET Amyris Brands Expanding in UK and Europe. Executing on continued accelerated growth and lower costs

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its...

Sep 07, 2022, 08:00 ET AMYRIS TO PARTICIPATE AT SEPTEMBER INVESTOR CONFERENCES

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its...

Aug 31, 2022, 16:06 ET AMYRIS PUBLISHES SECOND ANNUAL ESG REPORT

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its...

Aug 09, 2022, 08:00 ET AMYRIS, INC. REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its...

Aug 03, 2022, 08:00 ET AMYRIS TO PARTICIPATE AT THE UBS GENOMICS 2.0 AND MEDTECH INNOVATIONS SUMMIT

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its...

Jul 28, 2022, 08:00 ET AMYRIS TO HOST SECOND QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL ON AUGUST 9

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its...